https://1drv.ms/u/c/ee8499fdedecab31/IQDUjG_-TmV0QI5G7gVtU9idAcfTvE5v3myCbttGi8YGOlk?e=QAMyWK
Lathell Nutraceuticals develops advanced technology platforms designed to address major global health and nutrition challenges. These platforms combine nutritional science, ingredient innovation, and physiological intelligence systems to support improved metabolic health outcomes and next-generation food technologies.
SAFE SUGAR™ is a very-low-glycemic crystalline sweetener platform designed for large-scale food manufacturing, institutional nutrition systems, and metabolic-health-focused product reformulation.
The platform is engineered to preserve the key functional properties required in food processing while significantly reducing metabolic impact compared with conventional sugar.
OMNIPHYX is a physiological intelligence platform designed to analyze human biosignals and physiological patterns to support advanced health monitoring systems and future medical technologies.
The platform integrates signal analysis technologies with modular device architecture designed for future development of health monitoring tools and physiological intelligence systems.
Lathell Nutraceuticals conducts ongoing research into advanced ingredient technologies designed to improve metabolic health outcomes and support healthier global food systems.
These technologies are developed to support scalable food manufacturing solutions and institutional nutrition initiatives while maintaining functional performance required in modern food production.
The global sugar market exceeds $100 billion annually, creating a substantial opportunity for ingredient technologies capable of supporting healthier alternatives while maintaining functional performance for food manufacturers.
SAFE SUGAR is positioned as a very-low-glycemic ingredient platform designed to support this global transition toward improved metabolic health outcomes across modern food systems.
View Global Market OpportunityLathell Nutraceuticals works with ingredient manufacturers, food companies, research institutions, and public-health organizations to explore commercialization pathways for next-generation nutritional technologies.
Partnership discussions may include ingredient licensing, pilot collaborations, manufacturing alignment, and commercialization programs designed to support scalable deployment across global food systems.
Explore Licensing & PartnershipsLathell Nutraceuticals is focused on developing scalable technologies capable of supporting improved metabolic health, nutrition innovation, and future physiological intelligence systems designed for global deployment.

